drug · antibody
patient view →unasnemab
Phase 2updated 2mo agoby Tanabe Pharma Corp🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
targets
Repulsive guidance molecule A
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that